Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,057,769 | 637,344 | 309,622 | 386,035 | 365,963 |
| Marketable Securities | 1,075,000 | 440,000 | 515,000 | 215,000 | 60,000 |
| Receivables | 396,490 | 355,987 | 263,838 | 224,129 | 234,244 |
| Inventories | 95,396 | 78,608 | 52,956 | 43,245 | 34,051 |
| Other current assets | 152,491 | 78,895 | 67,572 | 76,686 | 29,310 |
| TOTAL | $2,839,568 | $1,630,268 | $1,234,005 | $968,277 | $748,069 |
| Non-Current Assets | |||||
| PPE Net | 127,935 | 131,506 | 200,358 | 170,080 | 107,490 |
| Intangibles | 3,153,354 | 3,360,995 | 3,658,964 | 3,926,664 | 3,905,811 |
| Other Non-Current Assets | 415,044 | 416,128 | 110,164 | 58,651 | 38,857 |
| TOTAL | $3,696,333 | $3,908,629 | $3,969,486 | $4,155,395 | $4,052,158 |
| Total Assets | $6,535,901 | $5,538,897 | $5,203,491 | $5,123,672 | $4,800,227 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 246,322 | 33,387 | 33,387 | 40,605 | 36,094 |
| Accounts payable and accrued liabilities | 26,945 | 45,732 | 40,602 | 24,368 | 22,415 |
| Accrued Expenses | 352,732 | 269,686 | 264,887 | 198,779 | 193,268 |
| TOTAL | $653,745 | $364,490 | $345,487 | $293,947 | $257,406 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,848,516 | 1,573,870 | 1,563,025 | 1,540,433 | 1,993,531 |
| Deferred Revenues | 2,546 | 4,720 | 5,414 | 8,618 | 1,123 |
| Other Non-Current Liabilities | 241,183 | 260,600 | 218,879 | 176,608 | 112,617 |
| TOTAL | $2,222,411 | $2,063,426 | $2,100,582 | $2,116,628 | $2,665,482 |
| Total Liabilities | $2,876,156 | $2,427,916 | $2,446,069 | $2,410,575 | $2,922,888 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,325 | 56,133 | 57,056 | 59,803 | 59,742 |
| Common Shares | 61 | 61 | 61 | 61 | 61 |
| Retained earnings | 1,160,366 | 1,068,287 | 841,522 | 918,428 | 529,379 |
| Other shareholders' equity | -134,352 | -223,393 | -197,791 | -140,878 | -317,333 |
| TOTAL | $3,659,745 | $3,110,981 | $2,757,422 | $2,713,097 | $1,877,339 |
| Total Liabilities And Equity | $6,535,901 | $5,538,897 | $5,203,491 | $5,123,672 | $4,800,227 |